Sorry, no content matched your criteria.
Featured Story
Why Valeant Pharmaceuticals (NYSE: VRX) Stock Tanked 7% After Philidor Split
Valeant (NYSE: VRX) stock tanked 7% to $102.95 Friday.
Shares sank after the company said it is ending its relationship with Philidor RX, a pharmacy used to boost sales of some of Valeant's pricey drugs.
Valeant (NYSE: VRX) stock tanked 7% to $102.95 Friday.
Shares sank after the company said it is ending its relationship with Philidor RX, a pharmacy used to boost sales of some of Valeant's pricey drugs.